Sree Rayalaseema Hi-Strength Hypo Limited has informed the Exchange that Board of Directors at its meeting held on May 30, 2025, recommended Final Dividend of 3 per equity share.
SRHHYPOLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.4 pts less than Nifty Microcap 250 and 6.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors, at its meeting on May 30, 2025, recommended a Final Dividend of Rs. 3 per equity share (face value Rs. 10), which is 30% on the paid-up equity share capital, subject to shareholder approval. The company also announced audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with auditors issuing an unmodified opinion. Standalone revenue from operations for FY25 stood at Rs. 63,782 lakhs (down from Rs. 86,601 lakhs in FY24, mainly due to the discontinuation of coal trading), while net profit rose to Rs. 9,267 lakhs (vs Rs. 8,042 lakhs in FY24). EPS for FY25 was Rs. 53.99 (standalone) and Rs. 50.96 (consolidated), up from Rs. 46.85 and Rs. 46.01 respectively. Exceptional items include the company's contribution towards setting up a 132 KV substation.
The 30% dividend is a healthy return on the face value and signals steady cash generation, but the sharp drop in revenue (from coal trading exit) means investors should focus on the chemicals segment's profitability. Rising profit and EPS despite revenue decline is a positive sign of margin improvement.